The lung in the immunocompromised patient. Infectious complications Part 1.
about
Respiratory Multiplex Polymerase Chain Reaction: An Important Diagnostic Tool in Immunocompromised Patients.In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol.Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.Fungal infections as a complication of therapy for sarcoidosis.Microbial aetiologic agents associated with pneumonia in immunocompromised hosts.Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidaseCytologic findings of acute leukemia in bronchoalveolar lavage fluid.[Immunodeficiency and immunocompromised patients. Opportunistic infection of the lungs].Surgical treatment of pulmonary aspergilloma.Transbronchial cryobiopsy in immunocompromised patients with pulmonary infiltrates: a pilot study.Partners in crime: co-infections in the developing world
P2860
Q33635844-1527AE18-2C1C-4837-99BA-7D61DA3CC64DQ33857777-C5169018-3E53-4634-BF90-A5613EC5F48AQ33981379-3D24DF7A-CB0B-450B-97C1-FE09B3450218Q34194089-7F80DA8F-F95D-42C8-AD6C-4B442279369AQ35372227-9F1353D5-5C8D-4EC2-989F-3BB016499DBAQ35534465-83C1A585-4292-4D6A-A562-38E947536C23Q36119381-DBA717A7-11DC-4E9A-B5AB-A8BF2E0C5A42Q36398126-E8C5A078-80AF-4D27-BCAE-7B1E56DF6FCCQ36692807-E3EAE197-61E5-4521-B0F4-01874C6DF433Q40267672-A2D2A5AF-18EC-43F7-BD94-B8A4B3A65295Q43894655-77D11424-BC86-4BD1-9B02-BF8E9BDEEE68Q44773188-60A63377-5F1F-4F1D-A045-0B06FDB74F3FQ45054861-2F25DDA0-D5AD-47FE-BECA-57AD2C1B0D92Q56920473-6B320D40-EB43-4268-B6EE-64DAA0ACE697
P2860
The lung in the immunocompromised patient. Infectious complications Part 1.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The lung in the immunocompromised patient. Infectious complications Part 1.
@ast
The lung in the immunocompromised patient. Infectious complications Part 1.
@en
type
label
The lung in the immunocompromised patient. Infectious complications Part 1.
@ast
The lung in the immunocompromised patient. Infectious complications Part 1.
@en
prefLabel
The lung in the immunocompromised patient. Infectious complications Part 1.
@ast
The lung in the immunocompromised patient. Infectious complications Part 1.
@en
P356
P1433
P1476
The lung in the immunocompromised patient. Infectious complications Part 1.
@en
P2093
Baughman RP
P304
P356
10.1159/000029349
P577
1999-01-01T00:00:00Z